Vitamin D Level in Recurrent PV
- Conditions
- Recurrent Pityriasis Versicolor
- Interventions
- Diagnostic Test: Human 25-Hydroxyvitamin D3 (HVD3) ELISA Kit (96 well)
- Registration Number
- NCT05067699
- Lead Sponsor
- Kasr El Aini Hospital
- Brief Summary
Serum Samples will be taken from patients with recurrent Pityriasis Versicolor for the evaluation of vitamin D level.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 200
Inclusion Criteria
-
- Patients with recurrent pityriasis versicolor (active now) and not taking treatment for it.
- Patients of both genders.
- Age ≥18 years old.
Exclusion Criteria
-
- Patients with other cutaneous diseases.
- Patient's having dandruff (scaly scalp) even if not symptomatizing.
- Pregnant and lactating females, children, prisoners, cognitively impaired or mentally disabled subjects.
- Patients with autoimmune diseases.
- Patients with immunodeficiency diseases.
- Immunosuppressed patients e.g. HIV, diabetics, organ transplant, malignancy, patients taking immunosuppressive drugs e.g. chemotherapy, cortisone.
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description Patients Human 25-Hydroxyvitamin D3 (HVD3) ELISA Kit (96 well) recurrent pityriasis versicolor Controls Human 25-Hydroxyvitamin D3 (HVD3) ELISA Kit (96 well) Healthy age and sex matched
- Primary Outcome Measures
Name Time Method Serum 25(OH) D3 level 6months-1 year The serum of patients and controls will be tested by a double-antibody sandwich enzyme-linked immunosorbent assay (ELISA) to assay the level of Human 25Dihydroxy vitamin D（25-OH-D).
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Kasr Al Ainy Teaching Hospital
🇪🇬Cairo, Egypt